Nathalie Adda, Senior VP & Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 73,540 shares at $70.26 ($5.2M) on 2022-03-01, disclosed to the SEC on 2022-03-03.
Open-market sale of $5.2M ENTA by Senior VP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.26 | 24,239 | $1.7M | 33.0% |
| 2 | $70.26 | 24,239 | $1.7M | 33.0% |
| 3 | $71.06 | 100 | $7K | 0.1% |
| 4 | $70.07 | 12,481 | $875K | 16.9% |
| 5 | $70.07 | 12,481 | $875K | 16.9% |
| Total | $70.20 avg | 73,540 |
| $5.2M |
| 100% |
| Filing → |
| ENTA | SELL | 2021-12-03 | $1.9M | — | Filing → |
| ENTA | SELL | 2021-11-02 | $1.6M | — | Filing → |
| ENTA | SELL | 2021-10-13 | $2.5M | — | Filing → |